Literature DB >> 1849455

Rapid analysis of glycolipid anchors in amphiphilic dimers of acetylcholinesterases.

J P Toutant1, J A Krall, M K Richards, T L Rosenberry.   

Abstract

1. We describe two simple procedures for the rapid identification of certain structural features of glycolipid anchors in acetylcholinesterases (AChEs). 2. Treatment with alkaline hydroxylamine (that cleaves ester-linked acyl chains but not ether-linked alkyl chains) converts molecules possessing a diacylglycerol, but not those with an alkylacylglycerol, into hydrophilic derivatives. AChEs in human and bovine erythrocytes possess an alkylacylglycerol (Roberts et al., J. Biol. Chem. 263:18766-18775, 1988; Biochem. Biophys. Res. Commun. 150:271-277, 1988) and are not converted to hydrophilic dimers by alkaline hydroxylamine. Amphiphilic dimers of AChE from Drosophila, from mouse erythrocytes, and from the human erythroleukaemia cell line K562 also resist the treatment with hydroxylamine and likely possess a terminal alkylacylglycerol. This indicates that the cellular pool of free glycolipids used as precursors of protein anchors is distinct from the pool of membrane phosphatidylinositols (which contain diacylglycerols). 3. Pretreatment with alkaline hydroxylamine is required to render the amphiphilic AChE from human erythrocytes susceptible to digestion by Bacillus thuringiensis phosphatidylinositol-specific phospholipase C (PI-PLC) (Toutant et al., Eur. J. Biochem. 180:503-508, 1989). We show here that this is also the case for the AChE from mouse erythrocytes, which therefore likely possesses an additional acyl chain in the anchor that prevents the action of PI-PLC. 4. In two sublines of K562 cells (48 and 243), we observed that AChE either was directly susceptible to PI-PLC (243) or required a prior deacylation by alkaline hydroxylamine (48). This suggests that glycolipid anchors in AChE of K562-48 cells, but not those in AChE of K562-243 cells, contain the additional acylation demonstrated in AChE from human erythrocytes. These observations illustrate the cell specificity (and the lack of species-specificity) of the structure of glycolipid anchors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849455     DOI: 10.1007/bf00712811

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  38 in total

1.  Alkylacylglycerol molecular species in the glycosylinositol phospholipid membrane anchor of bovine erythrocyte acetylcholinesterase.

Authors:  W L Roberts; J J Myher; A Kuksis; T L Rosenberry
Journal:  Biochem Biophys Res Commun       Date:  1988-01-15       Impact factor: 3.575

Review 2.  Identification and analysis of glycoinositol phospholipid anchors in membrane proteins.

Authors:  T L Rosenberry; J P Toutant; R Haas; W L Roberts
Journal:  Methods Cell Biol       Date:  1989       Impact factor: 1.441

3.  Differential susceptibility to phosphatidylinositol-specific phospholipase C of acetylcholinesterase in excitable tissues of embryonic and adult Torpedo ocellata.

Authors:  A H Futerman; D Raviv; D M Michaelson; I Silman
Journal:  Brain Res       Date:  1987-07       Impact factor: 3.252

4.  Conversion of human erythrocyte acetylcholinesterase from an amphiphilic to a hydrophilic form by phosphatidylinositol-specific phospholipase C and serum phospholipase D.

Authors:  J P Toutant; W L Roberts; N R Murray; T L Rosenberry
Journal:  Eur J Biochem       Date:  1989-04-01

5.  Molecular forms of acetylcholinesterase in two sublines of human erythroleukemia K562 cells. Sensitivity or resistance to phosphatidylinositol-specific phospholipase C and biosynthesis.

Authors:  J P Toutant; M K Richards; J A Krall; T L Rosenberry
Journal:  Eur J Biochem       Date:  1990-01-12

6.  Differences in the glycolipid membrane anchors of bovine and human erythrocyte acetylcholinesterases.

Authors:  W L Roberts; B H Kim; T L Rosenberry
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

7.  Acetylcholinesterase release from mammalian erythrocytes by phosphatidylinositol-specific phospholipase C of Bacillus thuringiensis and characterization of the released enzyme.

Authors:  R Taguchi; K Suzuki; T Nakabayashi; H Ikezawa
Journal:  J Biochem       Date:  1984-08       Impact factor: 3.387

8.  Cell-specific heterogeneity in sensitivity of phosphatidylinositol-anchored membrane antigens to release by phospholipase C.

Authors:  M G Low; J Stiernberg; G L Waneck; R A Flavell; P W Kincade
Journal:  J Immunol Methods       Date:  1988-10-04       Impact factor: 2.303

Review 9.  Glycosyl-phosphatidylinositol: a versatile anchor for cell surface proteins.

Authors:  M G Low
Journal:  FASEB J       Date:  1989-03       Impact factor: 5.191

10.  Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.

Authors:  M A Davitz; M G Low; V Nussenzweig
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

View more
  4 in total

1.  Endogenous butyrylcholinesterase in SV40 transformed cell lines: COS-1, COS-7, MRC-5 SV40, and WI-38 VA13.

Authors:  M Kris; O Jbilo; C F Bartels; P Masson; S Rhode; O Lockridge
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-10       Impact factor: 2.416

2.  Regulation of CD59 expression on K562 cells: effects of phorbol myristate acetate, cross-linking antibody and non-lethal complement attack.

Authors:  K J Marchbank; B P Morgan; C W van den Berg
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

3.  Calcium influxes and calmodulin modulate the expression and physicochemical properties of acetylcholinesterase molecular forms during development in vivo.

Authors:  L J Houenou; M V Sahuqué; A P Villageois
Journal:  Cell Mol Neurobiol       Date:  1993-06       Impact factor: 5.046

4.  Hupresin Retains Binding Capacity for Butyrylcholinesterase and Acetylcholinesterase after Sanitation with Sodium Hydroxide.

Authors:  Seda Onder; Emilie David; Ozden Tacal; Lawrence M Schopfer; Oksana Lockridge
Journal:  Front Pharmacol       Date:  2017-10-10       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.